The clinical use of enfortumab vedotin and pembrolizumab in patients with advanced urothelial carcinoma: using clinical judgement over treatment criteria.

Show more authors
+ 4
A B Apolo
J Bellmunt
L Cordes
S Gupta
T Powles
J E Rosenberg
M S Van Der Heijden

More about this publication

ESMO open

Volume 9
Issue nr. 9
Pages 103725
Publication date 01-09-2024

Full text links

Publisher website (DOI) 10.1016/j.esmoop.2024.103725
Europe PubMed Central 39236601
Pubmed 39236601

This site uses cookies

This website uses cookies to ensure you get the best experience on our website.